In Short Order -- Linda Elesgood, LDN Research Trust

November 2-8 is LDN Awareness Week.  The 2014 LDN AIIC Conference is raising awareness about a ground-breaking drug (LDN) that has proven beneficial in treating over 175 health conditions

Physicians, patients and experts from all over the world will gather in Las Vegas this November at a major conference to discuss and raise awareness about a ground-breaking drug that can help eradicate pain for those affected by a range of autoimmune diseases and conditions.

The LDN 2014 AIIC Conference 2014 will take place on the 7th and 8th November at the MEET in Las Vegas with a number of high profile medical experts confirmed to speak. The conference also coincides with LDN Awareness Week 2014 which runs from 2nd-8th November 2014.

Doctors around the world are now starting to realise the benefits of using LDN (Low Dose Naltrexone) to treat a range of conditions from Crohn’s and HIV to MS, ME, Lyme, arthritis, infertility and more.

 LDN has traditionally been used in higher doses (50mg) to treat drug/alcohol addicts but, since the 1980s, doctors have prescribed it in lower doses (3-4.5mg), and it is currently helping over a quarter of a million people worldwide suffering from a range of autoimmune conditions.

 As a result, and to raise awareness of how other people could be helped, the LDN Research Trust was set up in 2004. Since that time, the group’s popularity has grown rapidly with supporters from all over the world, including prominent physicians. 

 LDN works as an opiate antagonist, inhibiting natural endorphins thus forcing the body to produce more which, in turn, reduces painful symptoms and improves well-being and those using it have experienced a huge improvement in their conditions, with some disappearing altogether.

 The LDN 2014 AIIC Conference 2014 will include expert presenters and­ panelists, all streamed live.